Figure 2. Prevalence of Comorbid Conditions Following Bariatric Surgery.

Lines indicate modeled prevalence, bars, and 95% CI based on mixed models, adjusted for baseline factors independently related to missing follow-up data (ie, site, age, and smoking). Comorbidities were not assessed at 6 months or year 6. Data collection ended before the 7-year assessment of 498 Roux-en-Y gastric bypass and 202 laparoscopic adjustable gastric band participants. HDL indicates high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.